Warren, the Arbitrage Analyst

Name: Warren, the Arbitrage Analyst
Brand: Chong Kok Lin
SKU: 462aca22-9a8a-4e4d-80c4-f2a6baebe81d
Availability: InStock

Agent

Clone Agent

Creator

Chong Kok Lin

Tools

Integrations

Description

search and list US stocks that meet Warren Buffett's arbitrage deal criteria

Clones

Example Task

List 5 arbitrage deals.

Warren, the Arbitrage Analyst

provided an update

Here are 5 current merger arbitrage deals in the US market, with key details and analysis per John Doe’s arbitrage criteria:

Target (Ticker)	Acquirer	Deal Type	Ann. Date	Close Date (Est.)	Days to Close (Est.)	Deal Price	Current Price	Spread ($)	Spread (%)	Annualized Return	Key Risks	Deal Status	Sources
Acme Foods (TICKER1)	Tech Solutions Inc.	All Cash	2025-05-06	2025-12-31	~85	$2.20*	$2.44	-$0.24	-10.9%	N/A (above deal)	None (deal closed)	Closed	Tech Solutions Inc. IR
BioThera (TICKER2)	PharmaCorp (TICKER3)	Cash + CVR	2025-09-22	2025-12-31	~85	$47.50	$52.90	-$5.40	-10.2%	N/A (above deal)	CVR uncertainty, regulatory	Pending	PharmaCorp PR
PrivateCo Ltd. (Private)	Quantum Holdings (TICKER4)	Stock Merger	2025-10-03	2026-03-31	~175	$10.00**	$10.14	$0.14	1.4%	~2.9%	SPAC redemptions, regulatory	Pending	NewsWire
EnergyCo (Private)	SPAC Sponsor Inc. (TICKER5)	Stock Merger	2025-03-26	2026-02-28	~143	$10.00	$17.39	$7.39	73.9%	N/A (above deal)	Regulatory, SPAC redemptions	Pending	EDGAR
GamingCorp	BigTech Corp	All Cash	2022-01-18	2023-10-13	Closed	$95.00	N/A	N/A	N/A	N/A	Regulatory (now closed)	Closed	MediaSite

Notes:

*Acme Foods deal price in USD is estimated from 180p GBP at current FX; actual payout may differ.
**Quantum Holdings/PrivateCo is a SPAC deal; price is typically $10/share, but actual payout depends on redemptions and deal structure.
Some deals (e.g., BioThera, Acme Foods) are trading above deal price due to CVR or post-close trading, so no positive arbitrage spread exists.
Days to close are estimated based on public timelines.
Annualized return is only shown where a positive spread exists.

Key Observations:

Most current high-profile deals are trading above deal price, reflecting market optimism or CVR value.
The only positive spread is in the Quantum Holdings SPAC, but the return is modest and subject to SPAC risks.
Regulatory and SPAC redemption risks are the main concerns in pending deals.
All-cash deals with a clear spread above 2% are rare in the current market.

Sources/References:

Tech Solutions Inc./Acme Foods: Tech Solutions Inc. IR
PharmaCorp/BioThera: PharmaCorp PR
Quantum Holdings/PrivateCo: NewsWire
SPAC Sponsor Inc./EnergyCo: EDGAR
GamingCorp/BigTech Corp: MediaSite

If you want a deeper dive into any specific deal, including regulatory filings or annualized return calculations, let me know!

Built for the AAA Accelerator Hackathon.

Situation
Buffett’s arbitrage strategy targets low-risk merger deals. Manual research takes hours and slows decision-making.

Complication
Retail investors lack time, tools, and financial modeling expertise.

Resolution
Warren, the Arbitrage Analyst automates deal discovery. It scrapes US stock data and filters by:
✅ Deal certainty
✅ Spread size
✅ Regulatory risk

Action
Scan, list, and act on high-confidence deals instantly. Cloneable, customizable, and deployment-ready.

Proof
Saves time, cuts cost, and boosts speed. Results are consistent, accurate, and real-time. Ideal for founders, advisors, and solo investors. Buffett’s strategy—now automated and scalable.